At the end of the video is a frame which specifies the organisations involved.
RMIT university is clearly one (the first mentioned).
The others are Indian based government funded organisations (IICT and others).
Here is what I suspect to be the research paper:
https://www.researchgate.net/public...ticancer_drugs_to_HER2-positive_breast_cancer
It seems quite likely that there is Indian research which is running parallel to the SPL clinical trials. The dendrimer being used G4 PANAM, while similar to those in use by SPL is not I think the same one.
Its all pre clinical and running a couple of years behind, but catching up fast. This sort of competition could be the rationale for the lousy communications. It could of course impact the value of our research so big Pharma can just wait for a year or two and pay less.
- Forums
- ASX - By Stock
- Ann: DEP irinotecan synergistic with Lynparza in refractory model
At the end of the video is a frame which specifies the...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.5¢ | $35.24K | 364.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 18326 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 15262 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 18326 | 0.095 |
3 | 160000 | 0.094 |
3 | 134307 | 0.092 |
3 | 81442 | 0.090 |
1 | 30000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 15262 | 2 |
0.100 | 38876 | 3 |
0.105 | 199768 | 2 |
0.110 | 168286 | 9 |
0.115 | 85453 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
SPL (ASX) Chart |